• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JXHS1900191 拉莫三嗪分散片 lamotrigine Tablet Chemical Drugs(5.1) Import Drug Application 2020-01-13 The Wellcome Foundation Limited The Wellcome Foundation Ltd Certificate Issued 2021-03-01 view
JXHS1900194 拉莫三嗪分散片 lamotrigine Tablet Chemical Drugs(5.1) Import Drug Application 2020-01-13 The Wellcome Foundation Limited The Wellcome Foundation Ltd Certificate Issued 2021-03-01 view
JXHS1900193 拉莫三嗪分散片 lamotrigine Tablet Chemical Drugs(5.1) Import Drug Application 2020-01-13 The Wellcome Foundation Limited The Wellcome Foundation Ltd Certificate Issued 2021-03-01 view
JXHS1900192 拉莫三嗪分散片 lamotrigine Tablet Chemical Drugs(5.1) Import Drug Application 2020-01-13 The Wellcome Foundation Limited The Wellcome Foundation Ltd Certificate Issued 2021-03-01 view
JYHB2001436 拉莫三嗪分散片 lamotrigine Tablet Chemical Drugs Supplementary Application 2020-08-21 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Filed 2020-09-02 view
JYHB2001435 拉莫三嗪分散片 lamotrigine Tablet Chemical Drugs Supplementary Application 2020-08-21 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Filed 2020-09-02 view
JYHB2001434 拉莫三嗪分散片 lamotrigine Tablet Chemical Drugs Supplementary Application 2020-08-21 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Filed 2020-09-02 view
JYHB2001433 拉莫三嗪分散片 lamotrigine Tablet Chemical Drugs Supplementary Application 2020-08-21 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Filed 2020-09-02 view
JYHB2001437 拉莫三嗪分散片 lamotrigine Tablet Chemical Drugs Supplementary Application 2020-08-21 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Filed 2020-09-02 view
JYHB2001654 拉莫三嗪分散片 lamotrigine Tablet Chemical Drugs Supplementary Application 2020-09-02 哈药集团医药有限公司 HPGC Pharmaceutical Co Ltd In Review 2020-09-01 view
JYHB2001653 拉莫三嗪分散片 lamotrigine Tablet Chemical Drugs Supplementary Application 2020-09-02 哈药集团医药有限公司 HPGC Pharmaceutical Co Ltd In Review 2020-09-01 view
JYHB1901507 拉莫三嗪分散片 lamotrigine Tablet Chemical Drugs Supplementary Application 2019-12-09 哈药集团医药有限公司 HPGC Pharmaceutical Co Ltd Filed 2019-12-20 view
JYHB1901508 拉莫三嗪分散片 lamotrigine Tablet Chemical Drugs Supplementary Application 2019-12-09 哈药集团医药有限公司 HPGC Pharmaceutical Co Ltd Filed 2019-12-20 view
JXHS1700001 拉莫三嗪分散片 lamotrigine Tablet Chemical Drugs(5.1) Import Drug Application 2017-02-15 The Wellcome Foundation Limited The Wellcome Foundation Ltd Certificate Issued 2019-05-13 view
JXHS1500095 拉莫三嗪分散片 lamotrigine Tablet Chemical Drugs Import Drug Application 2015-10-26 The Wellcome Foundation Limited The Wellcome Foundation Ltd Certificate Issued 2019-01-03 view
JXHS1500093 拉莫三嗪分散片 lamotrigine Tablet Chemical Drugs Import Drug Application 2015-10-26 The Wellcome Foundation Limited The Wellcome Foundation Ltd Certificate Issued 2019-01-03 view
JXHS1500094 拉莫三嗪分散片 lamotrigine Tablet Chemical Drugs Import Drug Application 2015-10-26 The Wellcome Foundation Limited The Wellcome Foundation Ltd Certificate Issued 2019-01-03 view
JXHS1500096 拉莫三嗪分散片 lamotrigine Tablet Chemical Drugs Import Drug Application 2015-10-26 The Wellcome Foundation Limited The Wellcome Foundation Ltd Certificate Issued 2019-01-03 view
JXHS1500092 拉莫三嗪分散片 lamotrigine Tablet Chemical Drugs Import Drug Application 2015-10-26 The Wellcome Foundation Limited The Wellcome Foundation Ltd Certificate Issued 2019-01-03 view
JYHZ1700011 拉莫三嗪分散片 lamotrigine Tablet Chemical Drugs License Renew 2017-08-03 泰卫医药信息咨询(上海)有限公司 Teva Pharmaceutical Information Consulting (Shanghai) Co Ltd Certificate Issued 2018-07-19 view